Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
Paromomycin Topical Cream Treatment Protocol for Individuals With Uncomplicated Cutaneous Leishmaniasis
Sponsor: U.S. Army Medical Research and Development Command
A observational or N/A phase clinical study on Leishmaniasis, Cutaneous, this trial is ongoing. The trial is conducted by U.S. Army Medical Research and Development Command and has accumulated 12 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Jan 2021 — Jul 2024 [monthly]
No Longer Available
-
Jun 2020 — Jan 2021 [monthly]
No Longer Available
Status: Available → No Longer Available
-
Oct 2019 — Jun 2020 [monthly]
Available
▶ Show 7 earlier versions
-
Aug 2019 — Oct 2019 [monthly]
Available
-
Sep 2018 — Aug 2019 [monthly]
Available
-
Jun 2018 — Sep 2018 [monthly]
Available
-
Apr 2018 — Jun 2018 [monthly]
Available
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Available NA
-
Feb 2017 — Oct 2017 [monthly]
Available NA
-
Jan 2017 — Feb 2017 [monthly]
Available NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- U.S. Army Medical Research and Development Command
For direct contact, visit the study record on ClinicalTrials.gov .